Coexpression cluster:C0
From FANTOM5_SSTAR
Full id: C0_CD14_Eosinophils_Neutrophils_Basophils_CD34_immature_Peripheral
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
0.00425143795626119 | 0.0321247106720483 | 4 | 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate (KEGG):00532 |
0.00133776027585096 | 0.0130292062417945 | 6 | 40 | Sphingolipid metabolism (KEGG):00600 |
6.16097435632278e-08 | 2.00847764016123e-06 | 27 | 265 | Cytokine-cytokine receptor interaction (KEGG):04060 |
8.39741026616912e-05 | 0.00128322925629897 | 17 | 189 | Chemokine signaling pathway (KEGG):04062 |
2.2811600735419e-06 | 4.64786364984163e-05 | 13 | 86 | Apoptosis (KEGG):04210 |
2.16698707745994e-06 | 4.60720296033875e-05 | 16 | 128 | Osteoclast differentiation (KEGG):04380 |
2.85362180913581e-10 | 1.99345866381059e-08 | 19 | 102 | Toll-like receptor signaling pathway (KEGG):04620 |
1.43326395780318e-12 | 3.50433037682878e-10 | 17 | 59 | NOD-like receptor signaling pathway (KEGG):04621 |
2.98273796505281e-08 | 1.04182776065059e-06 | 14 | 71 | RIG-I-like receptor signaling pathway (KEGG):04622 |
4.65531906040374e-09 | 2.0695009277613e-07 | 14 | 62 | Cytosolic DNA-sensing pathway (KEGG):04623 |
0.00107643015425161 | 0.0107423335801845 | 13 | 155 | Jak-STAT signaling pathway (KEGG):04630 |
0.00033354698071338 | 0.00388343984687721 | 13 | 137 | Natural killer cell mediated cytotoxicity (KEGG):04650 |
0.00190037406991627 | 0.0165943378605189 | 10 | 108 | T cell receptor signaling pathway (KEGG):04660 |
0.000100819652716995 | 0.00149396394480637 | 10 | 75 | B cell receptor signaling pathway (KEGG):04662 |
0.00537229544723757 | 0.0380732242565098 | 7 | 69 | Adipocytokine signaling pathway (KEGG):04920 |
0.00023607564663386 | 0.00288602478009893 | 9 | 68 | Epithelial cell signaling in Helicobacter pylori infection (KEGG):05120 |
0.00294564280150295 | 0.0248348160333611 | 7 | 62 | Shigellosis (KEGG):05131 |
1.41068620075766e-05 | 0.000237870880058792 | 11 | 73 | Leishmaniasis (KEGG):05140 |
1.22241943948415e-07 | 3.73601941192344e-06 | 16 | 104 | Chagas disease (American trypanosomiasis) (KEGG):05142 |
0.000644660502273218 | 0.00700531079136897 | 6 | 35 | African trypanosomiasis (KEGG):05143 |
0.000157271928950184 | 0.00219731352161829 | 8 | 51 | Malaria (KEGG):05144 |
3.60455893689099e-06 | 7.05051728055877e-05 | 16 | 133 | Toxoplasmosis (KEGG):05145 |
1.60420729655662e-07 | 4.47983890382499e-06 | 16 | 106 | Amoebiasis (KEGG):05146 |
2.20733370460271e-09 | 1.07938618155073e-07 | 24 | 182 | Tuberculosis (KEGG):05152 |
0.000999859125799526 | 0.0101860648440827 | 12 | 135 | Hepatitis C (KEGG):05160 |
1.69402033826415e-07 | 4.47983890382499e-06 | 18 | 134 | Measles (KEGG):05162 |
1.00245240116991e-12 | 3.50433037682878e-10 | 28 | 176 | Influenza A (KEGG):05164 |
0.00307910681656379 | 0.0255200548016897 | 20 | 327 | Pathways in cancer (KEGG):05200 |
0.00581411580761335 | 0.0406157518560418 | 7 | 70 | Pancreatic cancer (KEGG):05212 |
0.00183366713695132 | 0.0163029678176217 | 8 | 73 | Chronic myeloid leukemia (KEGG):05220 |
0.00028880988830685 | 0.00344458622883048 | 10 | 85 | Small cell lung cancer (KEGG):05222 |
8.5954133337647e-07 | 2.00150339057664e-05 | 14 | 92 | Rheumatoid arthritis (KEGG):05323 |
0.00321712275182436 | 0.0262195504273685 | 10 | 116 | Androgen Receptor Signaling Pathway (Wikipathways):WP138 |
2.30975486902947e-08 | 8.68823177658008e-07 | 11 | 40 | NOD pathway (Wikipathways):WP1433 |
0.00403384949676599 | 0.031310355617755 | 3 | 11 | Osteopontin Signaling (Wikipathways):WP1434 |
5.53701938295192e-11 | 4.51267079710582e-09 | 23 | 140 | Regulation of toll-like receptor signaling pathway (Wikipathways):WP1449 |
1.61601545320517e-05 | 0.000263410518872442 | 10 | 61 | Selenium Pathway (Wikipathways):WP15 |
0.000180897593371529 | 0.00239078170699129 | 8 | 52 | Vitamin B12 Metabolism (Wikipathways):WP1533 |
0.000691494075529239 | 0.00735088267247386 | 8 | 63 | Folate Metabolism (Wikipathways):WP176 |
0.000367776116980188 | 0.00418238421403051 | 4 | 12 | IL-1 Signaling Pathway (Wikipathways):WP195 |
1.61580233506846e-06 | 3.59148791749308e-05 | 20 | 188 | TNF-alpha/NF-kB Signaling Pathway (Wikipathways):WP231 |
1.14986675996699e-05 | 0.000200816016294235 | 12 | 85 | Apoptosis (Wikipathways):WP254 |
1.74063270291768e-07 | 4.47983890382499e-06 | 8 | 22 | EBV LMP1 signaling (Wikipathways):WP262 |
0.00160898819308834 | 0.0147449332712717 | 13 | 162 | MAPK signaling pathway (Wikipathways):WP382 |
0.00385008824336014 | 0.0303660185645663 | 13 | 179 | EGFR1 Signaling Pathway (Wikipathways):WP437 |
0.00060441809326353 | 0.00671728290013332 | 9 | 77 | IL-2 Signaling Pathway (Wikipathways):WP49 |
0.00356449396276462 | 0.0285743860293754 | 4 | 21 | Hypertrophy Model (Wikipathways):WP516 |
0.00625774384747697 | 0.0425005102974478 | 6 | 54 | Id Signaling Pathway (Wikipathways):WP53 |
4.15950186831576e-06 | 7.53332005039409e-05 | 7 | 23 | Cytokines and Inflammatory Response (Wikipathways):WP530 |
6.02879889275282e-05 | 0.000950994405985848 | 12 | 100 | Senescence and Autophagy (Wikipathways):WP615 |
0.00427015581530295 | 0.0321247106720483 | 6 | 50 | Type II interferon signaling (IFNG) (Wikipathways):WP619 |
0.00283480940584391 | 0.0243196806922399 | 11 | 133 | T Cell Receptor Signaling Pathway (Wikipathways):WP69 |
0.00456467840515538 | 0.0338201172745603 | 7 | 67 | SIDS Susceptibility Pathways (Wikipathways):WP706 |
3.64203216596464e-11 | 3.56190745831342e-09 | 20 | 102 | Toll-like receptor signaling pathway (Wikipathways):WP75 |
2.68672083884993e-11 | 3.28451622549404e-09 | 47 | 511 | Signaling in Immune system (Reactome):REACT_6900 |
0.000175974305187767 | 0.00239031764546718 | 18 | 220 | Signalling by NGF (Reactome):REACT_11061 |
0.00142050460013546 | 0.0133582067205046 | 27 | 466 | Hemostasis (Reactome):REACT_604 |
0.00605054306298933 | 0.0416720501098843 | 11 | 147 | Apoptosis (Reactome):REACT_578 |
0.00135887427061661 | 0.0130292062417945 | 13 | 159 | EGFR1 up reg. targets (Netpath):NetPath_4 |
0.000923359216192706 | 0.00960686503655816 | 41 | 792 | TGF beta receptor up reg. targets (Netpath):NetPath_7 |
7.02643407662666e-09 | 2.86327188622536e-07 | 53 | 728 | TNF alpha/NF-kB up reg. targets (Netpath):NetPath_9 |
0.000156987196872601 | 0.00219731352161829 | 15 | 162 | TNF alpha/NF-kB down reg. targets (Netpath):NetPath_9 |
0.00499127425830448 | 0.0358931340045719 | 24 | 437 | AR up reg. targets (Netpath):NetPath_2 |
0.000200594694564588 | 0.00251514886261753 | 19 | 242 | B Cell Receptor up reg. targets (Netpath):NetPath_12 |
0.00495612963722777 | 0.0358931340045719 | 7 | 68 | T Cell Receptor down reg. targets (Netpath):NetPath_11 |
3.97380638898368e-10 | 2.42898915526627e-08 | 23 | 154 | IL-1 up reg. targets (Netpath):NetPath_13 |
1.60580701659313e-09 | 8.72488479015602e-08 | 38 | 408 | IL-2 up reg. targets (Netpath):NetPath_14 |
0.000200431451342285 | 0.00251514886261753 | 7 | 40 | IL-3 up reg. targets (Netpath):NetPath_15 |
4.10090011459927e-06 | 7.53332005039409e-05 | 21 | 217 | IL-4 up reg. targets (Netpath):NetPath_16 |
6.52648255274034e-07 | 1.59572498414501e-05 | 14 | 90 | IL-4 down reg. targets (Netpath):NetPath_16 |
1.14947300330197e-11 | 1.87364099538221e-09 | 23 | 130 | IL-5 up reg. targets (Netpath):NetPath_17 |
0.00162827483977233 | 0.0147449332712717 | 7 | 56 | IL-7 up reg. targets (Netpath):NetPath_19 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006915 | apoptosis | 2.82155838612429e-38 |
GO:0012501 | programmed cell death | 4.30019346162364e-38 |
GO:0042981 | regulation of apoptosis | 3.82648948649562e-37 |
GO:0008219 | cell death | 3.82648948649562e-37 |
GO:0016265 | death | 3.82648948649562e-37 |
GO:0043067 | regulation of programmed cell death | 9.79237786394369e-37 |
GO:0006952 | defense response | 4.52286243115286e-36 |
GO:0048468 | cell development | 4.38532462994828e-29 |
GO:0009611 | response to wounding | 1.69742030521152e-28 |
GO:0005515 | protein binding | 2.33064392541438e-28 |
GO:0048519 | negative regulation of biological process | 1.27326296722392e-26 |
GO:0048523 | negative regulation of cellular process | 5.83954096385085e-26 |
GO:0009605 | response to external stimulus | 2.52299407138837e-25 |
GO:0048869 | cellular developmental process | 3.47153444569286e-23 |
GO:0030154 | cell differentiation | 3.47153444569286e-23 |
GO:0008134 | transcription factor binding | 3.21149186137499e-20 |
GO:0042221 | response to chemical stimulus | 3.50768601539619e-20 |
GO:0005737 | cytoplasm | 3.50768601539619e-20 |
GO:0006950 | response to stress | 9.49390885459372e-20 |
GO:0032502 | developmental process | 2.26230536930081e-19 |
GO:0007243 | protein kinase cascade | 4.26811717177096e-19 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.58177148627513e-19 |
GO:0065007 | biological regulation | 3.21802439025239e-18 |
GO:0002376 | immune system process | 2.74639736238171e-17 |
GO:0044424 | intracellular part | 3.02318417547877e-17 |
GO:0006955 | immune response | 8.88609069086369e-17 |
GO:0043231 | intracellular membrane-bound organelle | 1.2315871002741e-16 |
GO:0043227 | membrane-bound organelle | 1.24580966345322e-16 |
GO:0048522 | positive regulation of cellular process | 1.32666633999274e-16 |
GO:0044464 | cell part | 1.43375613209818e-15 |
GO:0050789 | regulation of biological process | 1.67848645022775e-15 |
GO:0048518 | positive regulation of biological process | 1.82101148007379e-15 |
GO:0007154 | cell communication | 5.97725977850706e-15 |
GO:0005622 | intracellular | 1.53766800305527e-14 |
GO:0007165 | signal transduction | 1.91357639330645e-14 |
GO:0009607 | response to biotic stimulus | 7.01156789387207e-14 |
GO:0006954 | inflammatory response | 8.14521204875488e-14 |
GO:0050794 | regulation of cellular process | 8.16632892335978e-14 |
GO:0007242 | intracellular signaling cascade | 3.7694992246852e-13 |
GO:0043066 | negative regulation of apoptosis | 1.03727483182521e-12 |
GO:0043069 | negative regulation of programmed cell death | 1.35776338302123e-12 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 5.12768078779641e-12 |
GO:0008283 | cell proliferation | 1.19569595931674e-11 |
GO:0006916 | anti-apoptosis | 1.93129758626022e-10 |
GO:0009615 | response to virus | 3.71181433272232e-10 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 1.53366105792894e-09 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.12630028398356e-09 |
GO:0007626 | locomotory behavior | 4.67660036177271e-09 |
GO:0051707 | response to other organism | 5.09483202541185e-09 |
GO:0043229 | intracellular organelle | 7.03153349515065e-09 |
GO:0043226 | organelle | 7.25112627317426e-09 |
GO:0009892 | negative regulation of metabolic process | 8.76143317608488e-09 |
GO:0006935 | chemotaxis | 8.82638696589805e-09 |
GO:0042330 | taxis | 8.82638696589805e-09 |
GO:0007610 | behavior | 8.95702928372013e-09 |
GO:0031324 | negative regulation of cellular metabolic process | 1.62005710673607e-08 |
GO:0051704 | multi-organism process | 1.62531946449851e-08 |
GO:0031090 | organelle membrane | 2.3478276795309e-08 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 5.117600999026e-08 |
GO:0003712 | transcription cofactor activity | 7.98687831331886e-08 |
GO:0042127 | regulation of cell proliferation | 9.79816151494911e-08 |
GO:0005125 | cytokine activity | 1.23182864467458e-07 |
GO:0043065 | positive regulation of apoptosis | 1.54763727674924e-07 |
GO:0009967 | positive regulation of signal transduction | 1.58147530129321e-07 |
GO:0043068 | positive regulation of programmed cell death | 1.70468463835292e-07 |
GO:0044444 | cytoplasmic part | 2.25514851075708e-07 |
GO:0001775 | cell activation | 2.45063552660924e-07 |
GO:0016564 | transcription repressor activity | 3.44237195030314e-07 |
GO:0065008 | regulation of biological quality | 4.19556217735769e-07 |
GO:0005615 | extracellular space | 4.3012024609811e-07 |
GO:0046983 | protein dimerization activity | 7.99831860400417e-07 |
GO:0003714 | transcription corepressor activity | 1.11616923329408e-06 |
GO:0005887 | integral to plasma membrane | 1.14759226115259e-06 |
GO:0012505 | endomembrane system | 1.36137582980121e-06 |
GO:0006917 | induction of apoptosis | 1.74108984041341e-06 |
GO:0031226 | intrinsic to plasma membrane | 1.77442800656045e-06 |
GO:0012502 | induction of programmed cell death | 1.81058331661258e-06 |
GO:0065009 | regulation of a molecular function | 2.06098528185151e-06 |
GO:0019222 | regulation of metabolic process | 2.30076716342493e-06 |
GO:0009653 | anatomical structure morphogenesis | 2.45359089775718e-06 |
GO:0009966 | regulation of signal transduction | 2.99490168014221e-06 |
GO:0016044 | membrane organization and biogenesis | 3.40381947412256e-06 |
GO:0051246 | regulation of protein metabolic process | 3.40381947412256e-06 |
GO:0005102 | receptor binding | 7.21674198536009e-06 |
GO:0045321 | leukocyte activation | 7.21674198536009e-06 |
GO:0015031 | protein transport | 7.35482717135834e-06 |
GO:0008104 | protein localization | 1.01545018183615e-05 |
GO:0048856 | anatomical structure development | 1.13574820658782e-05 |
GO:0042107 | cytokine metabolic process | 1.13574820658782e-05 |
GO:0045184 | establishment of protein localization | 1.13574820658782e-05 |
GO:0033036 | macromolecule localization | 1.22925032159805e-05 |
GO:0016043 | cellular component organization and biogenesis | 1.22925032159805e-05 |
GO:0005634 | nucleus | 1.26908879102043e-05 |
GO:0001816 | cytokine production | 1.36612090277039e-05 |
GO:0045087 | innate immune response | 1.47765655059546e-05 |
GO:0045934 | negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 1.60827141009002e-05 |
GO:0046651 | lymphocyte proliferation | 1.63549245593885e-05 |
GO:0032943 | mononuclear cell proliferation | 1.63549245593885e-05 |
GO:0010324 | membrane invagination | 1.83513798410923e-05 |
GO:0006897 | endocytosis | 1.83513798410923e-05 |
GO:0016481 | negative regulation of transcription | 1.9390028258885e-05 |
GO:0000267 | cell fraction | 2.22554090171985e-05 |
GO:0005773 | vacuole | 2.52669001513912e-05 |
GO:0019955 | cytokine binding | 2.88662635299605e-05 |
GO:0051789 | response to protein stimulus | 3.51780051572191e-05 |
GO:0006986 | response to unfolded protein | 3.51780051572191e-05 |
GO:0004857 | enzyme inhibitor activity | 5.89627428229136e-05 |
GO:0016020 | membrane | 7.33392447406938e-05 |
GO:0031323 | regulation of cellular metabolic process | 7.88931376616658e-05 |
GO:0008285 | negative regulation of cell proliferation | 8.01430036312347e-05 |
GO:0042089 | cytokine biosynthetic process | 8.96930857765273e-05 |
GO:0050790 | regulation of catalytic activity | 9.15003574705003e-05 |
GO:0005764 | lysosome | 0.000113705978160445 |
GO:0000323 | lytic vacuole | 0.000118966186359792 |
GO:0005625 | soluble fraction | 0.000119799311106425 |
GO:0009891 | positive regulation of biosynthetic process | 0.000119799311106425 |
GO:0045595 | regulation of cell differentiation | 0.000120208830006632 |
GO:0032501 | multicellular organismal process | 0.000151952924171659 |
GO:0006928 | cell motility | 0.000151952924171659 |
GO:0051674 | localization of cell | 0.000151952924171659 |
GO:0044428 | nuclear part | 0.000151952924171659 |
GO:0031967 | organelle envelope | 0.000165225973085146 |
GO:0045727 | positive regulation of translation | 0.000165225973085146 |
GO:0031975 | envelope | 0.000176234544149473 |
GO:0009893 | positive regulation of metabolic process | 0.000224829558528669 |
GO:0046649 | lymphocyte activation | 0.000224829558528669 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 0.000224829558528669 |
GO:0009889 | regulation of biosynthetic process | 0.000229244936782068 |
GO:0042060 | wound healing | 0.000290634025120562 |
GO:0010468 | regulation of gene expression | 0.000311033851677216 |
GO:0044422 | organelle part | 0.000325594337086304 |
GO:0019965 | interleukin binding | 0.000325755725926754 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.000352198537174818 |
GO:0016021 | integral to membrane | 0.000355687059591395 |
GO:0031325 | positive regulation of cellular metabolic process | 0.000387140826751875 |
GO:0019210 | kinase inhibitor activity | 0.000422103933132849 |
GO:0005794 | Golgi apparatus | 0.000439533255244161 |
GO:0031224 | intrinsic to membrane | 0.000449791661990567 |
GO:0050793 | regulation of developmental process | 0.000511158220563289 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 0.000511284689175166 |
GO:0044446 | intracellular organelle part | 0.000511284689175166 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.000556950870843402 |
GO:0044425 | membrane part | 0.0005941559116859 |
GO:0030155 | regulation of cell adhesion | 0.000610734372986969 |
GO:0002521 | leukocyte differentiation | 0.00061817163159462 |
GO:0031988 | membrane-bound vesicle | 0.000646237996023023 |
GO:0006665 | sphingolipid metabolic process | 0.000723657169215303 |
GO:0045103 | intermediate filament-based process | 0.000723657169215303 |
GO:0004896 | hematopoietin/interferon-class (D200-domain) cytokine receptor activity | 0.000789023688173291 |
GO:0042104 | positive regulation of activated T cell proliferation | 0.00083105644625646 |
GO:0002520 | immune system development | 0.000832329179828814 |
GO:0006417 | regulation of translation | 0.000912877718189989 |
GO:0005070 | SH3/SH2 adaptor activity | 0.00091713472719007 |
GO:0005149 | interleukin-1 receptor binding | 0.00091713472719007 |
GO:0006807 | nitrogen compound metabolic process | 0.000927759553128225 |
GO:0005783 | endoplasmic reticulum | 0.000927759553128225 |
GO:0031410 | cytoplasmic vesicle | 0.000935578027622508 |
GO:0003700 | transcription factor activity | 0.00096138988813216 |
GO:0007275 | multicellular organismal development | 0.000988507170026859 |
GO:0043085 | positive regulation of catalytic activity | 0.00102372149616865 |
GO:0042110 | T cell activation | 0.00102643646773933 |
GO:0050792 | regulation of viral reproduction | 0.00112763132897539 |
GO:0031982 | vesicle | 0.00122152865484213 |
GO:0046006 | regulation of activated T cell proliferation | 0.00130480945138339 |
GO:0050798 | activated T cell proliferation | 0.00130480945138339 |
GO:0030097 | hemopoiesis | 0.00130480945138339 |
GO:0051345 | positive regulation of hydrolase activity | 0.00130480945138339 |
GO:0008009 | chemokine activity | 0.00130480945138339 |
GO:0005635 | nuclear envelope | 0.00132014703450103 |
GO:0030101 | natural killer cell activation | 0.001358486772226 |
GO:0051059 | NF-kappaB binding | 0.001358486772226 |
GO:0042379 | chemokine receptor binding | 0.00137735530470173 |
GO:0051093 | negative regulation of developmental process | 0.00137735530470173 |
GO:0051179 | localization | 0.00138157981065815 |
GO:0004907 | interleukin receptor activity | 0.00138157981065815 |
GO:0045637 | regulation of myeloid cell differentiation | 0.00138157981065815 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00149424988886489 |
GO:0031326 | regulation of cellular biosynthetic process | 0.00156687658257701 |
GO:0046519 | sphingoid metabolic process | 0.00156687658257701 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 0.00158504287341581 |
GO:0005829 | cytosol | 0.00161694006127387 |
GO:0006351 | transcription, DNA-dependent | 0.00179382860798935 |
GO:0006886 | intracellular protein transport | 0.00184531535604419 |
GO:0032774 | RNA biosynthetic process | 0.00187104828443725 |
GO:0006350 | transcription | 0.00195374029568989 |
GO:0048731 | system development | 0.0021130107996425 |
GO:0005886 | plasma membrane | 0.00219695700479453 |
GO:0015837 | amine transport | 0.00219695700479453 |
GO:0060090 | molecular adaptor activity | 0.00232874407908844 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.00232874407908844 |
GO:0051247 | positive regulation of protein metabolic process | 0.00232874407908844 |
GO:0033188 | sphingomyelin synthase activity | 0.00237619418841371 |
GO:0001660 | fever | 0.00237619418841371 |
GO:0019969 | interleukin-10 binding | 0.00237619418841371 |
GO:0047493 | ceramide cholinephosphotransferase activity | 0.00237619418841371 |
GO:0004920 | interleukin-10 receptor activity | 0.00237619418841371 |
GO:0005057 | receptor signaling protein activity | 0.00240047202560076 |
GO:0042098 | T cell proliferation | 0.00240047202560076 |
GO:0045449 | regulation of transcription | 0.00242989245792357 |
GO:0044421 | extracellular region part | 0.00259226750528049 |
GO:0000060 | protein import into nucleus, translocation | 0.00264405196243603 |
GO:0004860 | protein kinase inhibitor activity | 0.00265866190433511 |
GO:0044238 | primary metabolic process | 0.00266152219527465 |
GO:0005789 | endoplasmic reticulum membrane | 0.00275978420661588 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.00294987998788739 |
GO:0009308 | amine metabolic process | 0.00300814852704178 |
GO:0045596 | negative regulation of cell differentiation | 0.00326183470691838 |
GO:0007267 | cell-cell signaling | 0.00326183470691838 |
GO:0050755 | chemokine metabolic process | 0.00326183470691838 |
GO:0042033 | chemokine biosynthetic process | 0.00326183470691838 |
GO:0002263 | cell activation during immune response | 0.00326183470691838 |
GO:0002294 | CD4-positive, alpha-beta T cell differentiation during immune response | 0.00326183470691838 |
GO:0002285 | lymphocyte activation during immune response | 0.00326183470691838 |
GO:0002292 | T cell differentiation during immune response | 0.00326183470691838 |
GO:0032602 | chemokine production | 0.00326183470691838 |
GO:0042092 | T-helper 2 type immune response | 0.00326183470691838 |
GO:0042093 | T-helper cell differentiation | 0.00326183470691838 |
GO:0002366 | leukocyte activation during immune response | 0.00326183470691838 |
GO:0002286 | T cell activation during immune response | 0.00326183470691838 |
GO:0002293 | alpha-beta T cell differentiation during immune response | 0.00326183470691838 |
GO:0045787 | positive regulation of progression through cell cycle | 0.00341745913540001 |
GO:0042175 | nuclear envelope-endoplasmic reticulum network | 0.00352602718730107 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.00393174871000502 |
GO:0050878 | regulation of body fluid levels | 0.00398708508095322 |
GO:0007049 | cell cycle | 0.00415384449831152 |
GO:0006606 | protein import into nucleus | 0.00415384449831152 |
GO:0005319 | lipid transporter activity | 0.00415384449831152 |
GO:0016192 | vesicle-mediated transport | 0.00426171375586573 |
GO:0043367 | CD4-positive, alpha beta T cell differentiation | 0.00426444448837713 |
GO:0016070 | RNA metabolic process | 0.0044632180260162 |
GO:0048513 | organ development | 0.00447729929163255 |
GO:0046942 | carboxylic acid transport | 0.00458736949342454 |
GO:0051170 | nuclear import | 0.00458736949342454 |
GO:0001525 | angiogenesis | 0.00471475930186107 |
GO:0000074 | regulation of progression through cell cycle | 0.00481638801895165 |
GO:0015849 | organic acid transport | 0.00481638801895165 |
GO:0006968 | cellular defense response | 0.00507505929187313 |
GO:0007596 | blood coagulation | 0.00507505929187313 |
GO:0042592 | homeostatic process | 0.00514357214563959 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 0.00530327482144743 |
GO:0042226 | interleukin-6 biosynthetic process | 0.00530327482144743 |
GO:0042088 | T-helper 1 type immune response | 0.00530327482144743 |
GO:0042348 | NF-kappaB import into nucleus | 0.00530327482144743 |
GO:0051239 | regulation of multicellular organismal process | 0.00538713959256394 |
GO:0051726 | regulation of cell cycle | 0.00547101395066318 |
GO:0050817 | coagulation | 0.00553211840410787 |
GO:0019987 | negative regulation of anti-apoptosis | 0.00553736821903228 |
GO:0006686 | sphingomyelin biosynthetic process | 0.00553736821903228 |
GO:0008296 | 3'-5'-exodeoxyribonuclease activity | 0.00553736821903228 |
GO:0015917 | aminophospholipid transport | 0.00553736821903228 |
GO:0051223 | regulation of protein transport | 0.0055494623958941 |
GO:0003702 | RNA polymerase II transcription factor activity | 0.00555231662741092 |
GO:0044237 | cellular metabolic process | 0.00555231662741092 |
GO:0001664 | G-protein-coupled receptor binding | 0.00601953964958593 |
GO:0007219 | Notch signaling pathway | 0.0060301053817421 |
GO:0019058 | viral infectious cycle | 0.0060301053817421 |
GO:0008361 | regulation of cell size | 0.00614008991780483 |
GO:0006664 | glycolipid metabolic process | 0.00615570142066165 |
GO:0019079 | viral genome replication | 0.00615570142066165 |
GO:0002250 | adaptive immune response | 0.00615570142066165 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.00615570142066165 |
GO:0007599 | hemostasis | 0.00615570142066165 |
GO:0046982 | protein heterodimerization activity | 0.00615570142066165 |
GO:0045069 | regulation of viral genome replication | 0.00622328046715973 |
GO:0001836 | release of cytochrome c from mitochondria | 0.00622328046715973 |
GO:0046330 | positive regulation of JNK cascade | 0.00622328046715973 |
GO:0022402 | cell cycle process | 0.00622328046715973 |
GO:0005770 | late endosome | 0.00629077700141909 |
GO:0051251 | positive regulation of lymphocyte activation | 0.00629077700141909 |
GO:0030099 | myeloid cell differentiation | 0.00639082951216603 |
GO:0050671 | positive regulation of lymphocyte proliferation | 0.00670598489058402 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 0.00670598489058402 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00697926530695205 |
GO:0016604 | nuclear body | 0.00698659345429287 |
GO:0007264 | small GTPase mediated signal transduction | 0.00748620458810663 |
GO:0050900 | leukocyte migration | 0.00748620458810663 |
GO:0044451 | nucleoplasm part | 0.00748620458810663 |
GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 0.00748620458810663 |
GO:0001776 | leukocyte homeostasis | 0.00748620458810663 |
GO:0002252 | immune effector process | 0.0076207198285098 |
GO:0006953 | acute-phase response | 0.00830390236773259 |
GO:0006672 | ceramide metabolic process | 0.00830390236773259 |
GO:0030149 | sphingolipid catabolic process | 0.00903509977217233 |
GO:0032635 | interleukin-6 production | 0.00903509977217233 |
GO:0048872 | homeostasis of number of cells | 0.00903509977217233 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 0.00903509977217233 |
GO:0048514 | blood vessel morphogenesis | 0.00906041477253376 |
GO:0045628 | regulation of T-helper 2 cell differentiation | 0.00936255842864794 |
GO:0002467 | germinal center formation | 0.00936255842864794 |
GO:0031649 | heat generation | 0.00936255842864794 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 0.00936255842864794 |
GO:0048525 | negative regulation of viral reproduction | 0.00936255842864794 |
GO:0004942 | anaphylatoxin receptor activity | 0.00936255842864794 |
GO:0022415 | viral reproductive process | 0.00958609154743844 |
GO:0003713 | transcription coactivator activity | 0.010420405074686 |
GO:0045786 | negative regulation of progression through cell cycle | 0.010420405074686 |
GO:0046632 | alpha-beta T cell differentiation | 0.01059852377972 |
GO:0051336 | regulation of hydrolase activity | 0.0107260233697735 |
GO:0050863 | regulation of T cell activation | 0.0110182562004765 |
GO:0048646 | anatomical structure formation | 0.0111989336329861 |
GO:0003677 | DNA binding | 0.0116203788181476 |
GO:0043281 | regulation of caspase activity | 0.011766862976519 |
GO:0031901 | early endosome membrane | 0.0124856005982844 |
GO:0005768 | endosome | 0.0125751032849673 |
GO:0006643 | membrane lipid metabolic process | 0.0125751032849673 |
GO:0017038 | protein import | 0.0127025902386353 |
GO:0019207 | kinase regulator activity | 0.0127025902386353 |
GO:0019722 | calcium-mediated signaling | 0.013203461712667 |
GO:0005654 | nucleoplasm | 0.013203461712667 |
GO:0030674 | protein binding, bridging | 0.0133070848537221 |
GO:0044432 | endoplasmic reticulum part | 0.0134913819234328 |
GO:0030133 | transport vesicle | 0.0140249637397094 |
GO:0044459 | plasma membrane part | 0.0140249637397094 |
GO:0042100 | B cell proliferation | 0.0140249637397094 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.0140249637397094 |
GO:0045931 | positive regulation of progression through mitotic cell cycle | 0.0140249637397094 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 0.0140249637397094 |
GO:0045064 | T-helper 2 cell differentiation | 0.0140249637397094 |
GO:0046479 | glycosphingolipid catabolic process | 0.0140249637397094 |
GO:0004439 | phosphoinositide 5-phosphatase activity | 0.0140249637397094 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 0.0140249637397094 |
GO:0046521 | sphingoid catabolic process | 0.0140249637397094 |
GO:0001671 | ATPase activator activity | 0.0140249637397094 |
GO:0000902 | cell morphogenesis | 0.0143589885072513 |
GO:0032989 | cellular structure morphogenesis | 0.0143589885072513 |
GO:0045941 | positive regulation of transcription | 0.0143589885072513 |
GO:0030098 | lymphocyte differentiation | 0.0145016297326039 |
GO:0047485 | protein N-terminus binding | 0.0150839065927119 |
GO:0005164 | tumor necrosis factor receptor binding | 0.0150839065927119 |
GO:0016049 | cell growth | 0.0153205786855536 |
GO:0044255 | cellular lipid metabolic process | 0.0154215277577821 |
GO:0001568 | blood vessel development | 0.0156672545390817 |
GO:0008637 | apoptotic mitochondrial changes | 0.0157648660487551 |
GO:0046631 | alpha-beta T cell activation | 0.0157648660487551 |
GO:0046328 | regulation of JNK cascade | 0.0157648660487551 |
GO:0001944 | vasculature development | 0.0166915177205231 |
GO:0001817 | regulation of cytokine production | 0.0175841636467835 |
GO:0030217 | T cell differentiation | 0.0175841636467835 |
GO:0050870 | positive regulation of T cell activation | 0.0175841636467835 |
GO:0032813 | tumor necrosis factor receptor superfamily binding | 0.0175841636467835 |
GO:0043283 | biopolymer metabolic process | 0.018843989321751 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0190568595240103 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0190568595240103 |
GO:0050806 | positive regulation of synaptic transmission | 0.0191816686564672 |
GO:0043331 | response to dsRNA | 0.0191816686564672 |
GO:0005381 | iron ion transmembrane transporter activity | 0.0191816686564672 |
GO:0043029 | T cell homeostasis | 0.0191816686564672 |
GO:0010224 | response to UV-B | 0.0191816686564672 |
GO:0043027 | caspase inhibitor activity | 0.0191816686564672 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 0.0191816686564672 |
GO:0001848 | complement binding | 0.0191816686564672 |
GO:0006869 | lipid transport | 0.0196203427516284 |
GO:0004871 | signal transducer activity | 0.0196203427516284 |
GO:0060089 | molecular transducer activity | 0.0196203427516284 |
GO:0007050 | cell cycle arrest | 0.0196714590177986 |
GO:0006865 | amino acid transport | 0.0196714590177986 |
GO:0006023 | aminoglycan biosynthetic process | 0.0196714590177986 |
GO:0030148 | sphingolipid biosynthetic process | 0.0196714590177986 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0196714590177986 |
GO:0042991 | transcription factor import into nucleus | 0.0196714590177986 |
GO:0043028 | caspase regulator activity | 0.0196714590177986 |
GO:0019221 | cytokine and chemokine mediated signaling pathway | 0.0196934673497123 |
GO:0031981 | nuclear lumen | 0.0220531533072953 |
GO:0009968 | negative regulation of signal transduction | 0.0221161848092111 |
GO:0046209 | nitric oxide metabolic process | 0.0221161848092111 |
GO:0033157 | regulation of intracellular protein transport | 0.0221161848092111 |
GO:0042306 | regulation of protein import into nucleus | 0.0221161848092111 |
GO:0006809 | nitric oxide biosynthetic process | 0.0221161848092111 |
GO:0042802 | identical protein binding | 0.0239023293935593 |
GO:0022414 | reproductive process | 0.0245131519419456 |
GO:0030595 | leukocyte chemotaxis | 0.0245131519419456 |
GO:0051092 | activation of NF-kappaB transcription factor | 0.0245131519419456 |
GO:0001819 | positive regulation of cytokine production | 0.0245131519419456 |
GO:0019377 | glycolipid catabolic process | 0.0245131519419456 |
GO:0045604 | regulation of epidermal cell differentiation | 0.0245131519419456 |
GO:0051971 | positive regulation of transmission of nerve impulse | 0.0245131519419456 |
GO:0045622 | regulation of T-helper cell differentiation | 0.0245131519419456 |
GO:0001659 | thermoregulation | 0.0245131519419456 |
GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity | 0.0245131519419456 |
GO:0033176 | proton-transporting V-type ATPase complex | 0.0245131519419456 |
GO:0016471 | vacuolar proton-transporting V-type ATPase complex | 0.0245131519419456 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0253073470548377 |
GO:0009101 | glycoprotein biosynthetic process | 0.0256057451325749 |
GO:0051249 | regulation of lymphocyte activation | 0.0260758135225752 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.026087260859116 |
GO:0051234 | establishment of localization | 0.0263666055598251 |
GO:0046466 | membrane lipid catabolic process | 0.0269400336786535 |
GO:0001669 | acrosome | 0.0269400336786535 |
GO:0051049 | regulation of transport | 0.0273044318264008 |
GO:0046907 | intracellular transport | 0.0279874968188689 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.0292559455175994 |
GO:0032386 | regulation of intracellular transport | 0.0299173830068333 |
GO:0042102 | positive regulation of T cell proliferation | 0.0299173830068333 |
GO:0002526 | acute inflammatory response | 0.0299784500933799 |
GO:0043280 | positive regulation of caspase activity | 0.0306933325274749 |
GO:0016895 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.0306933325274749 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 0.0306933325274749 |
GO:0019915 | sequestering of lipid | 0.0306933325274749 |
GO:0031646 | positive regulation of neurological process | 0.0306933325274749 |
GO:0045682 | regulation of epidermis development | 0.0306933325274749 |
GO:0004529 | exodeoxyribonuclease activity | 0.0306933325274749 |
GO:0050865 | regulation of cell activation | 0.0309928193412919 |
GO:0003924 | GTPase activity | 0.0313942531088067 |
GO:0008284 | positive regulation of cell proliferation | 0.0328903069278898 |
GO:0016477 | cell migration | 0.0328903069278898 |
GO:0043170 | macromolecule metabolic process | 0.0337712062668649 |
GO:0051090 | regulation of transcription factor activity | 0.0346756150412983 |
GO:0006913 | nucleocytoplasmic transport | 0.0346756150412983 |
GO:0048770 | pigment granule | 0.0353182088369929 |
GO:0016607 | nuclear speck | 0.0353182088369929 |
GO:0042470 | melanosome | 0.0353182088369929 |
GO:0002274 | myeloid leukocyte activation | 0.0354761656694557 |
GO:0051169 | nuclear transport | 0.0366617103186341 |
GO:0045670 | regulation of osteoclast differentiation | 0.0376955757790339 |
GO:0045073 | regulation of chemokine biosynthetic process | 0.0376955757790339 |
GO:0015082 | di-, tri-valent inorganic cation transmembrane transporter activity | 0.0387960606718683 |
GO:0051649 | establishment of cellular localization | 0.0406218330745613 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0427001747422165 |
GO:0005275 | amine transmembrane transporter activity | 0.0427001747422165 |
GO:0006810 | transport | 0.0447547309812191 |
GO:0051338 | regulation of transferase activity | 0.0450335032710592 |
GO:0045089 | positive regulation of innate immune response | 0.0450335032710592 |
GO:0015988 | energy coupled proton transport, against electrochemical gradient | 0.0450335032710592 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 0.0450335032710592 |
GO:0048146 | positive regulation of fibroblast proliferation | 0.0450335032710592 |
GO:0002260 | lymphocyte homeostasis | 0.0450335032710592 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 0.0450335032710592 |
GO:0006368 | RNA elongation from RNA polymerase II promoter | 0.0450335032710592 |
GO:0007005 | mitochondrion organization and biogenesis | 0.0450335032710592 |
GO:0019838 | growth factor binding | 0.0450335032710592 |
GO:0008632 | apoptotic program | 0.0450335032710592 |
GO:0009306 | protein secretion | 0.0451842717202546 |
GO:0006629 | lipid metabolic process | 0.0452437599223196 |
GO:0002573 | myeloid leukocyte differentiation | 0.0452437599223196 |
GO:0051091 | positive regulation of transcription factor activity | 0.0452437599223196 |
GO:0010467 | gene expression | 0.0460152262916316 |
GO:0009628 | response to abiotic stimulus | 0.0465636780063174 |
GO:0035091 | phosphoinositide binding | 0.0483747971942848 |
GO:0009100 | glycoprotein metabolic process | 0.0486674180329717 |
GO:0051051 | negative regulation of transport | 0.0490225225908803 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
bone marrow | 3.75e-71 | 76 |
bone element | 1.83e-65 | 82 |
hematopoietic system | 2.57e-60 | 98 |
blood island | 2.57e-60 | 98 |
skeletal element | 4.79e-59 | 90 |
immune system | 6.40e-57 | 93 |
hemolymphoid system | 4.50e-54 | 108 |
skeletal system | 1.89e-52 | 100 |
musculoskeletal system | 1.73e-28 | 167 |
lateral plate mesoderm | 3.02e-25 | 203 |
connective tissue | 6.59e-15 | 371 |
mesoderm | 1.76e-13 | 315 |
mesoderm-derived structure | 1.76e-13 | 315 |
presumptive mesoderm | 1.76e-13 | 315 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0 |
MA0004.1 | 1.11544 |
MA0006.1 | 0 |
MA0007.1 | 4.5062e-11 |
MA0009.1 | 1.43528 |
MA0014.1 | 0 |
MA0017.1 | 0.011188 |
MA0019.1 | 1.93756 |
MA0024.1 | 5.42916e-14 |
MA0025.1 | 22.3857 |
MA0027.1 | 0.140052 |
MA0028.1 | 0 |
MA0029.1 | 0.952728 |
MA0030.1 | 0.270778 |
MA0031.1 | 0.36435 |
MA0038.1 | 4.24892 |
MA0040.1 | 4.0786 |
MA0041.1 | 4.26459 |
MA0042.1 | 1.6404 |
MA0043.1 | 24.7312 |
MA0046.1 | 0.186479 |
MA0048.1 | 0 |
MA0050.1 | 73.8079 |
MA0051.1 | 33.7499 |
MA0052.1 | 13.2761 |
MA0055.1 | 0 |
MA0056.1 | 0 |
MA0057.1 | 0 |
MA0058.1 | 1.84858 |
MA0059.1 | 0.00357571 |
MA0060.1 | 0 |
MA0061.1 | 47.5321 |
MA0063.1 | 0 |
MA0066.1 | 0.365589 |
MA0067.1 | 2.02941 |
MA0068.1 | 0 |
MA0069.1 | 1.69004 |
MA0070.1 | 1.99351 |
MA0071.1 | 7.59878 |
MA0072.1 | 11.6236 |
MA0073.1 | 0 |
MA0074.1 | 0.0866062 |
MA0076.1 | 0 |
MA0077.1 | 1.41014 |
MA0078.1 | 9.02666 |
MA0081.1 | 19.095 |
MA0083.1 | 1.3804 |
MA0084.1 | 1.39156 |
MA0087.1 | 5.49778 |
MA0088.1 | 0 |
MA0089.1 | 0 |
MA0090.1 | 0.724867 |
MA0091.1 | 1.84208 |
MA0092.1 | 1.87417 |
MA0093.1 | 1.88889 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 6.1109e-09 |
MA0101.1 | 83.1469 |
MA0103.1 | 0 |
MA0105.1 | 4.88949e-06 |
MA0106.1 | 2.31631e-13 |
MA0107.1 | 140.396 |
MA0108.2 | 3.50426 |
MA0109.1 | 0 |
MA0111.1 | 0.000343328 |
MA0113.1 | 0.620266 |
MA0114.1 | 1.67529e-08 |
MA0115.1 | 0.529326 |
MA0116.1 | 0 |
MA0117.1 | 0.0654224 |
MA0119.1 | 1.52927e-05 |
MA0122.1 | 1.62726 |
MA0124.1 | 1.629 |
MA0125.1 | 0.568921 |
MA0130.1 | 0 |
MA0131.1 | 0 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.13653 |
MA0136.1 | 51.4555 |
MA0139.1 | 0 |
MA0140.1 | 0.951066 |
MA0141.1 | 0.29159 |
MA0142.1 | 6.56023 |
MA0143.1 | 2.91076 |
MA0144.1 | 1.19938 |
MA0145.1 | 0 |
MA0146.1 | 0 |
MA0147.1 | 0 |
MA0148.1 | 4.41667 |
MA0149.1 | 6.12348e-15 |
MA0062.2 | 0 |
MA0035.2 | 2.52552 |
MA0039.2 | 0 |
MA0138.2 | 2.41082e-16 |
MA0002.2 | 12.2851 |
MA0137.2 | 1.75127 |
MA0104.2 | 0 |
MA0047.2 | 1.99336 |
MA0112.2 | 0 |
MA0065.2 | 0 |
MA0150.1 | 141.619 |
MA0151.1 | 0 |
MA0152.1 | 9.68363 |
MA0153.1 | 0.0738614 |
MA0154.1 | 4.33947e-15 |
MA0155.1 | 0 |
MA0156.1 | 46.7855 |
MA0157.1 | 1.41144 |
MA0158.1 | 0 |
MA0159.1 | 0 |
MA0160.1 | 2.42853 |
MA0161.1 | 0 |
MA0162.1 | 0 |
MA0163.1 | 0 |
MA0164.1 | 4.23742 |
MA0080.2 | 103.004 |
MA0018.2 | 1.38677 |
MA0099.2 | 456.177 |
MA0079.2 | 0 |
MA0102.2 | 21.1829 |
MA0258.1 | 1.48806e-10 |
MA0259.1 | 0 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BATF#10538 | 1898 | 4.52226428658831 | 0 | 0 |
BCL11A#53335 | 1369 | 3.7990593795205 | 0 | 0 |
BCL3#602 | 592 | 2.00057564900842 | 8.48333551822493e-58 | 7.50839896769401e-55 |
CEBPB#1051 | 2939 | 2.29161722315359 | 0 | 0 |
EBF1#1879 | 2212 | 1.92713534819629 | 4.04719890644526e-213 | 2.0127876504297e-209 |
EP300#2033 | 2968 | 1.96664961786466 | 2.09297571088206e-318 | 2.18588290283634e-314 |
ESR1#2099 | 415 | 1.24904336964728 | 2.47894288092809e-06 | 8.74656471423139e-05 |
FOS#2353 | 3001 | 2.64138353536067 | 0 | 0 |
FOSL1#8061 | 913 | 3.54675714379816 | 3.33253677358266e-252 | 2.32031205397467e-248 |
FOSL2#2355 | 1249 | 2.06845549790644 | 1.50678078702171e-135 | 3.83821167355513e-132 |
FOXA2#3170 | 494 | 1.19020337413838 | 3.99254653238326e-05 | 0.000741689020447484 |
GATA1#2623 | 904 | 1.19911166604672 | 6.9068635667662e-09 | 5.39525747232233e-07 |
GATA2#2624 | 1752 | 2.18420428418141 | 8.849671371124e-222 | 5.13472682404899e-218 |
GTF2F1#2962 | 949 | 1.18262136085719 | 3.40278966888747e-08 | 2.27664285860947e-06 |
IRF4#3662 | 1341 | 2.87463186079662 | 7.62665558832024e-278 | 5.68943059277556e-274 |
JUN#3725 | 2809 | 3.43818225582244 | 0 | 0 |
JUNB#3726 | 1150 | 3.44343417380361 | 3.62749017877847e-308 | 3.15709538984537e-304 |
JUND#3727 | 2981 | 2.03962566866062 | 0 | 0 |
MAFF#23764 | 415 | 2.28610710587178 | 5.51519914622225e-55 | 4.53544790261658e-52 |
MAFK#7975 | 1003 | 2.65890984419871 | 1.37134074622533e-179 | 4.62004697403315e-176 |
MAX#4149 | 2038 | 1.28634531227199 | 3.0731580805811e-35 | 1.51395073951797e-32 |
MEF2A#4205 | 1385 | 2.53931084905185 | 1.54481642571488e-232 | 9.49053427560211e-229 |
MEF2C#4208 | 681 | 2.75193508847471 | 7.7496491030809e-128 | 1.75949044060145e-124 |
NFE2#4778 | 308 | 2.32602096064773 | 1.57749076009736e-42 | 9.69126808787106e-40 |
NFKB1#4790 | 2874 | 1.54286357049135 | 8.24717640886996e-141 | 2.15331714241492e-137 |
NR3C1#2908 | 1214 | 1.77807398259259 | 2.68525048572668e-87 | 3.59544712152318e-84 |
PAX5#5079 | 1837 | 1.19847323493824 | 1.3831218913685e-17 | 2.94199322225325e-15 |
PBX3#5090 | 515 | 1.10397867882943 | 0.0103680832434365 | 0.0384979644420402 |
POLR2A#5430 | 4880 | 1.02509747643582 | 0.00762970330486184 | 0.0314396758120523 |
POLR3A#11128 | 65 | 2.15627380964133 | 7.14116702412256e-09 | 5.54922874131202e-07 |
POU2F2#5452 | 1407 | 1.25328343433862 | 1.74734070245535e-19 | 4.22431749129015e-17 |
PRDM1#639 | 197 | 2.54041849634743 | 1.12758828978964e-32 | 5.05425722735365e-30 |
RAD21#5885 | 1164 | 1.17903349841643 | 1.47098532611819e-09 | 1.30858804492724e-07 |
RXRA#6256 | 584 | 1.14678434992212 | 0.00032725402108409 | 0.00333542331492157 |
SIRT6#51548 | 169 | 2.53985036430737 | 3.08294595074528e-28 | 1.12580346905555e-25 |
SMARCA4#6597 | 169 | 2.59155215289378 | 2.99237637823681e-29 | 1.15748443172842e-26 |
SMARCB1#6598 | 641 | 1.14447723913938 | 0.000207926519591037 | 0.00242226857552351 |
SMARCC1#6599 | 615 | 2.62672072596824 | 2.38686329914534e-106 | 4.45145743034714e-103 |
SMARCC2#6601 | 210 | 1.9341317254865 | 1.49932186492197e-19 | 3.66715869439311e-17 |
SMC3#9126 | 820 | 1.20677344545094 | 1.30186946512873e-08 | 9.61569625661808e-07 |
SPI1#6688 | 2640 | 2.11869451848772 | 0 | 0 |
SRF#6722 | 900 | 1.21465914466898 | 7.21083451154662e-10 | 6.85252361739234e-08 |
STAT1#6772 | 866 | 1.7540746133791 | 7.84186091937372e-59 | 7.44541920507701e-56 |
STAT2#6773 | 362 | 2.31101292864047 | 3.79426640285603e-49 | 2.75187075588806e-46 |
STAT3#6774 | 3470 | 3.57062932017267 | 0 | 0 |
TAL1#6886 | 537 | 1.56895697503525 | 7.62002606221439e-25 | 2.4189297930444e-22 |
TCF12#6938 | 1282 | 1.33359913964619 | 4.64000980853966e-27 | 1.61532661464691e-24 |
TFAP2A#7020 | 722 | 1.16662956249031 | 9.15310623816763e-06 | 0.000244423743903858 |
TFAP2C#7022 | 1050 | 1.11021129221884 | 0.000163174490568725 | 0.00202999173561729 |
TRIM28#10155 | 694 | 1.26203896912963 | 1.96500018244104e-10 | 2.03796081483575e-08 |
USF1#7391 | 1779 | 1.10702408433463 | 1.09681313843764e-06 | 4.55286436269032e-05 |
USF2#7392 | 1257 | 1.59749507121515 | 6.90836954259062e-63 | 6.74302062297777e-60 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data